These mast cells reduce the proliferative and invasive capacity of glioma cells and induce their differentiation by depleting the potency of glioma stem cells, possibly by inactivating the STAT3-mediated pathway through GSK3β downregulation[41]. This evidence concerns the gene GSK3B and central nervous system cancer.